<<Disclaimer: Verify this information before applying it to your situation.>>

BTG, an international company specializing in the development and marketing
of innovative medical and physical science technologies, has acquired
rights to Dr. Robert Anderson's and Oxford University's technology that
could lead to better gluten intolerance testing and a potential celiac
disease vaccine or therapy.  Private industry has now officially entered
the market to fund and develop a treatment for celiac disease.  Stock
investors, take note!

http://www.devicelink.com/bw/3419.html

* Send administrative questions to [log in to unmask] *